This signaling cascade seems to be preferentially used by GSCs, while in non-stem tumor cells derived from the same GBM patients no expression of Sema3C or Plexin-A2/D1 receptors has been detected [33]. The gene discussed is SEMA3C; the disease is glioblastoma.